This level of tumor suppression observed is significantly higher compared to mutant KRAS knockout PDA cell growth of subcutaneous tumors in mice27, implicating a relationship of CEACAM6 to KRAS in PDA that needs further investigation. The gene discussed is KRAS; the disease is Patent ductus arteriosus.